2013/02/15 6:00 PM

Neovacs launches EUR 6.3 Million capital increase to finance clinical proof-of-concept for the TNF-Kinoid

Information only available in PDF version.


This publication embed "🔒 Actusnews SECURITY MASTER".
- SECURITY MASTER Key: nGhxaZlmYWmam26dl8dta2psbZuVw2OabGiamWhvZsyam29pyGxnb8aaZm9onmdr
- Check this key: https://www.security-master-key.com.